Stocks Above the 200-Day Moving Average · Services-Commercial Physical & Biological Research
9 stocks match the Stocks Above the 200-Day Moving Average screen. Stocks trading above their 200-day moving average — a long-term uptrend filter, largest first. Filtered to Services-Commercial Physical & Biological Research. Data as of close · Checked
| IQV | IQVIA | 0.73 | 8.94 | -1.29% | -0.53% | +26.15% | Golden | 48.01 | 36.7% | Bearish | Bearish | -6.83% | +71.44% | +0.99% | Double Bottom | Hammer | 264.87 | +0.43% |
| INCY | Incyte | 0.43 | 4.01 | +2.19% | -1.51% | +8.87% | Golden | 50.76 | 50.3% | Bullish | Bullish | -11.02% | +32.16% | +1.24% | Double Top | Bearish Engulfing | 117.98 | -4.02% |
| MEDP | Medpace Holdings, Inc. | 0.62 | 21.91 | -1.59% | +2.16% | +19.81% | Golden | 47.99 | 30.0% | Bearish | Bullish | -8.45% | +69.35% | -0.05% | Double Bottom | — | 635.08 | -3.25% |
| CRL | Charles River Laboratories | 1.12 | 16.34 | -5.36% | +2.66% | +39.70% | Golden | 45.26 | 19.3% | Bearish | Bullish | -17.51% | +113.98% | +0.53% | — | — | 312.93 | -4.10% |
| ABSI | Absci Corp | 3.54 | 1.01 | -4.62% | -2.29% | +41.12% | Golden | 46.72 | 25.5% | Bearish | Bearish | -25.50% | +316.74% | -3.52% | — | — | 9.34 | -11.10% |
| OABI | OmniAb, Inc. | 1.09 | 0.35 | -1.19% | +2.84% | +74.37% | Golden | 49.50 | 41.8% | Bearish | Bullish | -11.15% | +267.94% | +0.68% | Symmetrical Triangle | Bearish Marubozu | 4.82 | -6.86% |
| NRC | Nrc Health | 0.55 | 1.17 | +14.97% | +18.57% | +32.33% | Golden | 65.07 | 75.6% | Bullish | Strongly Bullish | -6.36% | +116.40% | +0.31% | Symmetrical Triangle | — | 25.47 | -5.75% |
| MXCT | MAXCYTE, INC. | 1.21 | 0.11 | -5.37% | +2.94% | +21.65% | Golden | 46.39 | 5.2% | Bearish | Bullish | -27.98% | +101.99% | -1.81% | — | — | 1.30 | -5.80% |
| ICLR | Icon Plc | 1.17 | 9.24 | +8.28% | +15.60% | +38.00% | Golden | 63.79 | 66.8% | Bullish | Strongly Bullish | -7.87% | +203.11% | +0.79% | — | — | 201.81 | -0.60% |
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.